Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck KGaA
Biotech
Merck KGaA lands new R&D chief—Chutes & Ladders
Merck KGaA lands new R&D chief. Cartography maps expanded leadership team. Psychedelic CEO steps down.
Darren Incorvaia
,
Zoey Becker
Sep 5, 2025 8:30am
Merck KGaA swoops to $2B neurological disease pact with Skyhawk
Aug 18, 2025 9:49am
Merck KGaA sheds light on failed portion of phase 2 lupus trial
Jun 12, 2025 9:41am
Protara gears up for next commercial steps—Chutes & Ladders
Jun 6, 2025 8:30am
Merck KGaA posts tumor data ahead of showdown with Daiichi, Ono
May 28, 2025 8:45am
After setback, Merck KGaA shows data justifying lupus ph. 3 push
May 21, 2025 9:50am